1. Home
  2. DRUG vs PESI Comparison

DRUG vs PESI Comparison

Compare DRUG & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • PESI
  • Stock Information
  • Founded
  • DRUG 2019
  • PESI 1990
  • Country
  • DRUG United States
  • PESI United States
  • Employees
  • DRUG N/A
  • PESI N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • PESI Environmental Services
  • Sector
  • DRUG Health Care
  • PESI Industrials
  • Exchange
  • DRUG Nasdaq
  • PESI Nasdaq
  • Market Cap
  • DRUG 199.7M
  • PESI 205.4M
  • IPO Year
  • DRUG N/A
  • PESI 1992
  • Fundamental
  • Price
  • DRUG $48.75
  • PESI $9.12
  • Analyst Decision
  • DRUG Strong Buy
  • PESI
  • Analyst Count
  • DRUG 9
  • PESI 0
  • Target Price
  • DRUG $81.67
  • PESI N/A
  • AVG Volume (30 Days)
  • DRUG 72.8K
  • PESI 268.7K
  • Earning Date
  • DRUG 08-11-2025
  • PESI 11-12-2025
  • Dividend Yield
  • DRUG N/A
  • PESI N/A
  • EPS Growth
  • DRUG N/A
  • PESI N/A
  • EPS
  • DRUG N/A
  • PESI N/A
  • Revenue
  • DRUG N/A
  • PESI $60,019,000.00
  • Revenue This Year
  • DRUG N/A
  • PESI $8.35
  • Revenue Next Year
  • DRUG N/A
  • PESI $82.81
  • P/E Ratio
  • DRUG N/A
  • PESI N/A
  • Revenue Growth
  • DRUG N/A
  • PESI N/A
  • 52 Week Low
  • DRUG $0.94
  • PESI $6.25
  • 52 Week High
  • DRUG $79.02
  • PESI $16.25
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 66.11
  • PESI 33.79
  • Support Level
  • DRUG $39.70
  • PESI $8.02
  • Resistance Level
  • DRUG $46.44
  • PESI $12.32
  • Average True Range (ATR)
  • DRUG 3.25
  • PESI 0.82
  • MACD
  • DRUG 0.20
  • PESI -0.37
  • Stochastic Oscillator
  • DRUG 93.56
  • PESI 25.58

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About PESI Perma-Fix Environmental Services Inc.

Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.

Share on Social Networks: